Thomas Feldthus

An entrepreneur with extensive strategic financial management experience within the life science industry. Thomas is cofounder of Saniona, Scandion Oncology Initiator Pharma, Symphogen, and Ataxion. Thomas’ previous roles include CFO of Saniona, CFO of Symphogen and Investment Associate at Novo A/S and Corporate Development Manager at Novo Nordisk.